Stromal issues in cervical cancer: a review of the role and function of basement membrane, stroma, immune response and angiogenesis in cervical cancer …
S Sahebali, G Van den Eynden, EF Murta… - European Journal of …, 2010 - journals.lww.com
The carcinogenesis of cervical carcinoma implies an intricate interplay of neoplastic, human
papillomavirus infected epithelial cells and stromal tissue, in which different factors have …
papillomavirus infected epithelial cells and stromal tissue, in which different factors have …
Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy
F Benchetrit, A Gazagne, O Adotevi, N Haicheur… - Bulletin du cancer, 2003 - jle.com
Le traitement de patients atteints de mélanomes par l'injection de cellules tumorales
autologues irradiées et traitées chimiquement au DNP a permis de démontrer l'expansion …
autologues irradiées et traitées chimiquement au DNP a permis de démontrer l'expansion …
Lipid-protamine-DNA-mediated antigen delivery
DP Vangasseri, SJ Han, L Huang - Current Drug Delivery, 2005 - ingentaconnect.com
The development of novel'new generation'vaccine systems that is based on proteins,
peptides or DNA is of great current interest. However, due to the lower efficiencies of these …
peptides or DNA is of great current interest. However, due to the lower efficiencies of these …
Характеристика интерферонового и иммунного статуса у больных с папилломавирусной инфекцией
АА Кубанов - Вестник дерматологии и венерологии, 2005 - elibrary.ru
При заражении вирусом папилломы человека (ВПЧ), как правило, развивается
патологический процесс, клинические проявления которого могут быть обу-словлены …
патологический процесс, клинические проявления которого могут быть обу-словлены …
Induction of unresponsiveness limits tumor protection by adoptively transferred MDM2-specific cytotoxic T lymphocytes
GM Bendle, A Holler, LK Pang, S Hsu, M Krampera… - Cancer research, 2004 - AACR
There is evidence showing that high avidity CTLs can be more effective than low avidity
CTLs for adoptive tumor immunotherapy. Because many T cell–recognized tumor antigens …
CTLs for adoptive tumor immunotherapy. Because many T cell–recognized tumor antigens …
[PDF][PDF] Papillomavirus vaccines
MF Duggan-Keen, MD Brown, SN Stacey… - Front …, 1998 - pure.manchester.ac.uk
[Frontiers in Bioscience 3, d1192-1208, December 1, 1998] 1192 PAPILLOMAVIRUS
VACCINES Margaret F. Duggan-Keen, Michael D. Brown Page 1 [Frontiers in Bioscience 3 …
VACCINES Margaret F. Duggan-Keen, Michael D. Brown Page 1 [Frontiers in Bioscience 3 …
A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour
T Doan, K Herd, I Ramshaw, S Thomson… - Cancer Immunology …, 2005 - Springer
Vaccine-induced CD8 T cells directed to tumour-specific antigens are recognised as
important components of protective and therapeutic immunity against tumours. Where …
important components of protective and therapeutic immunity against tumours. Where …
Synthetic peptides induce a cytotoxic response against human papillomavirus type-18
MR Castellanos, RL Hayes, MA Maiman - Gynecologic oncology, 2001 - Elsevier
Objectives. Over 90% of cervical carcinomas express human papillomavirus (HPV) E6 and
E7 proteins. These unique antigens are ideal targets for the development of cytotoxic T …
E7 proteins. These unique antigens are ideal targets for the development of cytotoxic T …
Investigation of the Optimal Prime Boost Spacing Regimen for a Cancer Therapeutic Vaccine Targeting Human Papillomavirus
DM Da Silva, EA Martinez, L Bogaert, WM Kast - Cancers, 2022 - mdpi.com
Simple Summary The selection of a therapeutic vaccine schedule can influence the
magnitude, efficacy, and durability of immune responses. This study aims to test different …
magnitude, efficacy, and durability of immune responses. This study aims to test different …
Role of non-anchor residues of Db-restricted peptides in class I binding and TCR triggering
LJ Sigal, DE Wylie - Molecular immunology, 1996 - Elsevier
To understand better, the role of non-anchor residues of class I restricted T cell epitopes in
class I binding and TCR stimulation, a panel of peptides was synthesized in which each of …
class I binding and TCR stimulation, a panel of peptides was synthesized in which each of …